First-line nivolumab plus ipilimumab versus chemotherapy for the treatment of unresectable malignant pleural mesothelioma: patient-reported outcomes in CheckMate 743.
Lung Cancer
; 167: 8-16, 2022 05.
Article
in En
| MEDLINE
| ID: mdl-35367910
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Mesothelioma, Malignant
/
Lung Neoplasms
/
Mesothelioma
Type of study:
Clinical_trials
/
Diagnostic_studies
/
Etiology_studies
/
Prognostic_studies
Aspects:
Patient_preference
Limits:
Humans
Language:
En
Journal:
Lung Cancer
Journal subject:
NEOPLASIAS
Year:
2022
Document type:
Article
Country of publication:
Ireland